Cellectis SA
PAR:ALCLS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
ALCLS Price Targets Summary
Cellectis SA
According to Wall Street analysts, the average 1-year price target for
ALCLS
is 6.63 EUR
with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALCLS's stock price target?
Price Target
6.63
EUR
According to Wall Street analysts, the average 1-year price target for
ALCLS
is 6.63 EUR
with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.
What is Cellectis SA's Revenue forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Cellectis SA's revenue is
10%.
The projected
CAGR
for the next 4 years is
14%.
